当前位置: X-MOL 学术Neurochem. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Promising Polyphenols in Parkinson's Disease Therapeutics.
Neurochemical Research ( IF 4.4 ) Pub Date : 2020-05-27 , DOI: 10.1007/s11064-020-03058-3
Ashish Singh 1 , Pratibha Tripathi 2 , Arun Kumar Yadawa 1 , Sarika Singh 1
Affiliation  

Abstract

Parkinson’s disease (PD) is a slow progressive, second most common neurodegenerative disease characterized by the loss of dopaminergic neurons from the nigrostriatal pathway. In spite of extensive research the therapeutics options of disease are limited which only offer symptomatic relief and could not prevent the disease progression. Therefore researchers are looking for the probable synthetic or natural compounds for the PD therapeutics. Due to mandatory chronic consumption of anti PD drug to the PD patients, the natural compounds are getting attention recently. Numerous studies have indicated the neuroprotective effects of natural polyphenols including epigallocatechin, quercetin, baicalein, resveratrol, luteolin, curcumin, puerarin, genistein, hyperoside naringin against dopaminergic neuronal death with relatively safe with uncommon, mild or transient side effects. However, their mechanistic interference in dopaminergic neuronal death mechanism is not very well defined. Herein, we have attempted to discuss the various natural polyphenols with their known effects on various PD related pathologies to understand their therapeutic utilization for PD patients either in prophylactic or therapeutic mode. Briefly we have also discussed the major disease mechanisms which could be targeted for utilization of these polyphenols specifically involving oxidative stress and mitochondrial dysfunction. We have also discuss the limitation and probable strategies for the clinical utilization of these polyphenols for the benefit of PD patients.

Graphic Abstract



中文翻译:

帕金森氏病治疗中有前景的多酚。

摘要

帕金森氏病(PD)是一种缓慢的进行性疾病,是第二常见的神经退行性疾病,其特征是黑质纹状体途径失去了多巴胺能神经元。尽管进行了广泛的研究,但是疾病的治疗选择是有限的,其仅提供症状缓解而不能阻止疾病的进展。因此,研究人员正在寻找可能用于PD治疗的合成或天然化合物。由于PD患者必须长期服用抗PD药物,因此天然化合物近来受到关注。大量研究表明,天然多酚包括表没食子儿茶素,槲皮素,黄ical素,白藜芦醇,木犀草素,姜黄素,葛根素,染料木黄酮,高糖苷柚皮苷对多巴胺能神经元死亡具有神经保护作用,相对安全,但不常见,轻度或短暂的副作用。但是,它们对多巴胺能神经元死亡机制的机械干扰还不是很清楚。本文中,我们试图讨论各种天然多酚对各种PD相关病理的已知作用,以了解其在预防或治疗模式下对PD患者的治疗应用。简要地,我们还讨论了主要的疾病机制,这些机制可能是针对这些多酚的利用,特别是涉及氧化应激和线粒体功能障碍。我们还讨论了这些多酚对PD患者的临床应用的局限性和可能的​​策略。我们试图讨论各种天然多酚及其对各种PD相关病理的已知作用,以了解其在预防或治疗模式下对PD患者的治疗应用。简要地,我们还讨论了主要的疾病机制,这些机制可能是针对这些多酚的利用,特别是涉及氧化应激和线粒体功能障碍。我们还讨论了这些多酚对PD患者的临床应用的局限性和可能的​​策略。我们试图讨论各种天然多酚及其对各种PD相关病理的已知作用,以了解其在预防或治疗模式下对PD患者的治疗应用。简要地,我们还讨论了主要的疾病机制,这些机制可能是针对这些多酚的利用,特别是涉及氧化应激和线粒体功能障碍。我们还讨论了这些多酚对PD患者的临床应用的局限性和可能的​​策略。简要地,我们还讨论了主要的疾病机制,这些机制可能是针对这些多酚的利用,特别是涉及氧化应激和线粒体功能障碍。我们还讨论了这些多酚对PD患者的临床应用的局限性和可能的​​策略。简要地,我们还讨论了主要的疾病机制,这些机制可能是针对这些多酚的利用,特别是涉及氧化应激和线粒体功能障碍。我们还讨论了这些多酚对PD患者的临床应用的局限性和可能的​​策略。

图形摘要

更新日期:2020-05-27
down
wechat
bug